About GEMCITABIN E 1000MG/25M
Antimetabolite chemotherapy medicine
Used for
- Treats pancreatic cancer
- Treats non-small-cell lung cancer
- Treats breast cancer
- Treats ovarian and bladder cancers
Usual adult dose
Typically 1,000–1,250 mg/m² by intravenous infusion, depending on cancer and regimen; schedules vary.
Common side effects
- Low blood-cell counts
- Nausea and vomiting
- Fever or flu-like symptoms
- Rash and hair loss
Important warnings
- Can cause serious infections or bleeding from low blood-cell counts.
- Rarely causes severe lung, liver, kidney, or skin problems.
- Use only under specialist supervision; blood tests and monitoring are required.
- Avoid live vaccines during treatment; discuss vaccination with the oncology team.
Pregnancy
May harm an unborn baby. Avoid during pregnancy; effective contraception is recommended during treatment and for six months afterward.
Breastfeeding
Breastfeeding is not recommended during treatment and for at least one week after the final dose.
Interactions
- Radiotherapy may increase tissue damage.
- Other chemotherapy or medicines affecting blood counts may increase toxicity.
- Warfarin may require closer monitoring of blood clotting.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.